Black Rock Inc. Coherus Bio Sciences, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CHRS
# of Institutions
120Shares Held
58.3MCall Options Held
82KPut Options Held
31K-
Vanguard Group Inc Valley Forge, PA10.6MShares$9.72 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$4.69 Million0.22% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.79 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA2.68MShares$2.46 Million0.0% of portfolio
-
Cm Management, LLC2.25MShares$2.07 Million1.68% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $71.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...